EVALUATION OF LDL-C REDUCTIONS BY SIRNA TREATMENT WITH INCLISIRAN IN PATIENTS WITH DIABETES MELLITUS, METABOLIC SYNDROME OR NEITHER
Authors:
- R. Scott WrightRWR. Scott Wright
- David KallendDKDavid Kallend
- Kausik Kumar RayKRKausik Kumar Ray
- Lawrence LeiterLLLawrence Leiter
- Wolfgang KoenigWKWolfgang Koenig
- Frederick RaalFRFrederick Raal
- Peter WijngaardPWPeter Wijngaard
- John J.P. KasteleinJKJohn J.P. Kastelein